Your browser doesn't support javascript.
loading
FAM13A is associated with non-small cell lung cancer (NSCLC) progression and controls tumor cell proliferation and survival.
Eisenhut, Felix; Heim, Lisanne; Trump, Sonja; Mittler, Susanne; Sopel, Nina; Andreev, Katerina; Ferrazzi, Fulvia; Ekici, Arif B; Rieker, Ralf; Springel, Rebekka; Assmann, Vera L; Lechmann, Matthias; Koch, Sonja; Engelhardt, Marina; Warnecke, Christina; Trufa, Denis I; Sirbu, Horia; Hartmann, Arndt; Finotto, Susetta.
Afiliação
  • Eisenhut F; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Heim L; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Trump S; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Mittler S; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Sopel N; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Andreev K; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Ferrazzi F; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Ekici AB; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Rieker R; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Springel R; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Assmann VL; Department of Immune Modulation, Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Lechmann M; Department of Immune Modulation, Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Koch S; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Engelhardt M; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Warnecke C; Department of Medicine 4, Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Trufa DI; Department of Thoracic Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Sirbu H; Department of Thoracic Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Hartmann A; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
  • Finotto S; Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg , Erlangen, Germany.
Oncoimmunology ; 6(1): e1256526, 2017.
Article em En | MEDLINE | ID: mdl-28197372
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha